New PSA Review Finds Modest Benefit, but Not Routine Screening
A May 2026 Cochrane review found that PSA screening likely prevents a small number of prostate-cancer deaths, but current U.S. guidance still favors shared decision-making for men 55 to 69 rather than routine testing for everyone.
